GREY:IMVIF - Post Discussion
IMV Inc
> FDA new accelerated approval (May 19th)
Post by
Breakthorough1 on Jun 04, 2023 3:57pm
FDA new accelerated approval (May 19th)
The response rate is similar to that of DPX in February. But the toxicity is much much higher. It's reslly absurd not to give a chance to DPX:
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-epcoritamab-bysp-relapsed-or-refractory-diffuse-large-b-cell
Be the first to comment on this post